Boston-based strategy consulting firm Innosight has added Roy Davis as a director. Davis was most recently Vice President of Corporate Development for all of Johnson & Johnson as well as President of Johnson & Johnson Development Corp.
The innovation consulting firm Innosight announced today that it is expanding its board of directors with the appointment of Roy Davis as a director of the firm, effective March 1. Mr. Davis was most recently Vice President of Corporate Development for all of Johnson & Johnson (J&J) as well as President of Johnson & Johnson Development Corporation (JJDC), where he was responsible for the management and efforts of both JJDC and the creation of Red Script(TM) Ventures.
“We are delighted to welcome Roy Davis. As a proven leader with extensive strategic and management experience at one of the world’s most-admired companies, he will be a tremendous asset as we work to shape the course of Innosight’s long-term growth,” said Richard N. Foster, Innosight’s lead director. “His global perspective and ventures expertise will be invaluable.”
In his role at Johnson & Johnson, Mr. Davis was responsible for acquisition and licensing in areas outside current J&J business sectors, venture capital investing on behalf of J&J, and management of J&J’s wholly owned ventures. These efforts are focused on developing new companies for J&J that offer transformational health care solutions.
Mr. Davis joined the Johnson & Johnson Family of Companies in 1984. He moved through line leadership positions of increasing responsibility in the organization in the U.S., Europe and Asia and then to Company Group Chairman and Worldwide Franchise Chairman for Diagnostics in 2003, before assuming his most recent role in January 2008. On January 1, 2012, Mr. Davis retired from J&J.
Mr. Davis also serves as a member of the Industrial Advisory Board of the Cleveland Clinic.
Mr. Davis received a Bachelor of Science from the State University of New York and a Master of Science from Rensselaer Polytechnic Institute.
Innosight is an innovation and strategy consulting firm with offices in Boston, Singapore, and India. It works with leading companies, including more than one-third of the Fortune 50, to devise new growth strategies, build innovation capabilities, and to create disruptive new products and services. Its comprehensive end-to-end approach helps companies convert the quest for innovation and growth into a predictable and systematic process.